The Anthrax Vaccine:

Is It Safe? Does It Work?

Status: Available Now

Size: 288 pages, 6 x 9

Publication Year:2002

Print	List Price


PAPERBACK ISBN-10: 0-309-08309-5 ISBN-13: 978-0-309-08309-6	$37.00	Add to Cart

PDF			About PDF

Authors:
Lois M. Joellenbeck, Lee L. Zwanziger, Jane S. Durch, and Brian L. Strom, Editors, Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Medical Follow-Up Agency
Authoring Organizations

Description:
The vaccine used to protect humans against the anthrax disease, called Anthrax Vaccine Adsorbed (AVA), was licensed in 1970. It was initially used to protect people who might be exposed to anthrax where they worked, such as veterinarians and textile ...
Read More

Paste into your Web page:

<!-- Start NAP Book Display -->
<object classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=8,0,0,0" width="175" height="250" id="napbookwrapper" align="middle">
<param name="allowScriptAccess" value="always" />
<param name="movie" value="http://www.nap.edu/napbookwrapper.swf" />
<param name="quality" value="high" />
<param name="wmode" value="transparent" />
<param name="flashvars" value="wid=381071792402012021202328&record_id=10310" />
<embed src="http://www.nap.edu/napbookwrapper.swf" quality="high" flashvars="wid=381071792402012021202328&record_id=10310" wmode="transparent" bgcolor="#ffffff" width="175" height="250" name="napbookwrapper" align="middle" allowScriptAccess="always" allowFullScreen="false" type="application/x-shockwave-flash" pluginspage="http://www.macromedia.com/go/getflashplayer"></embed>
</object>

Preview

Free Resources

Full Text
Jump to this book's table of contents to begin reading online for free.

PDF Summary
Download the summary in PDF.

Reprint Permission
Request permission to license or reprint the book's content through Copyright Clearance Center's Rightslink.

Request Permission to Distribute a PDF

Request Translation Rights

Questions About Rights and Permissions?

Table of Contents
Select a link below to start reading online free!
Front Matter	i-xxii
Executive Summary	1-32	(skim)
1 Introduction	33-39	(skim)
2 Background	40-55	(skim)
3 Anthrax Vaccine Efficacy	56-82	(skim)
4 Safety: Introduction	83-101	(skim)
5 Safety: Case Reports	102-117	(skim)
6 Safety: Epidemiologic Studies	118-179	(skim)
7 Anthrax Vaccine Manufacture	180-197	(skim)
8 Future Needs	198-210	(skim)
Appendix A Statement of Task	211-213	(skim)
Appendix B Biographical Sketches	214-217	(skim)
Appendix C Information-Gathering Meeting Agendas	218-226	(skim)
Appendix D Anthrax Vaccine Adsorbed Package Inserts	227-238	(skim)
Appendix E Vaccine Adverse Event Reporting System (VAERS) Form	239-242	(skim)
Appendix F Anthrax Vaccine Expert Committee (AVEC) Case Assessment Form	243-244	(skim)
Appendix G DMSS Analyses Requested by the IOM Committee to Assess the Safety and Efficacy of the Anthrax Vaccine	245-252	(skim)
Appendix H An Assessment of the Safety of the Anthrax Vaccine: A Letter Report	253-266	(skim)

Description

The vaccine used to protect humans against the anthrax disease, called Anthrax Vaccine Adsorbed (AVA), was licensed in 1970. It was initially used to protect people who might be exposed to anthrax where they worked, such as veterinarians and textile plant workers who process animal hair. When the U. S. military began to administer the vaccine, then extended a plan for the mandatory vaccination of all U. S. service members, some raised concerns about the safety and efficacy of AVA and the manufacture of the vaccine. In response to these and other concerns, Congress directed the Department of Defense to support an independent examination of AVA.

The Anthrax Vaccine: Is It Safe? Does It Work? reports the study s conclusion that the vaccine is acceptably safe and effective in protecting humans against anthrax. The book also includes a description of advances needed in main areas: improving the way the vaccine is now used, expanding surveillance efforts to detect side effects from its use, and developing a better vaccine.